Top compounds associated with response to IER5L


Feature Type Standardized
Nominal ANOVA
mRNA prima-1 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA PLX4720 GDSC1000 pan-cancer AAC 0.028 0.4
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Teniposide CTRPv2 pan-cancer AAC -0.034 0.4
mRNA YM-155 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA AT7867 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA QL-XI-92 GDSC1000 pan-cancer AAC -0.027 0.4
mRNA MLN4924 GDSC1000 pan-cancer AAC -0.035 0.4
mRNA KIN001-266 GDSC1000 pan-cancer AAC 0.029 0.5
Download CSV